antipyrine has been researched along with nicotine in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (29.03) | 18.7374 |
1990's | 2 (6.45) | 18.2507 |
2000's | 14 (45.16) | 29.6817 |
2010's | 6 (19.35) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Caron, G; Ermondi, G | 1 |
Jolivette, LJ; Ward, KW | 1 |
Carrupt, PA; Martel, S; Ottaviani, G | 2 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Breckenridge, AM; Ohnhaus, EE; Park, BK | 1 |
Jusko, WJ | 1 |
Klatzo, I; Nowak, TS; Tomida, S; Wagner, HG | 1 |
Ask, P; Michel, ME; Oberg, PA; Rapoport, SI; Rundquist, I; Smith, QR | 1 |
Page, JG; Vesell, ES | 1 |
Oldendorf, WH | 1 |
Chinard, FP; Effros, RM | 1 |
Kamat, UG; Pradhan, RJ; Sheth, UK | 1 |
Dawson, GW; Vestal, RE | 1 |
Acuff, V; Bereczki, D; Chen, JL; Fenstermacher, JD; Ghersi-Egea, JF; Hans, FJ; Otsuka, T; Patlak, C; Wei, L | 1 |
Chance, MB; Goddijn-Wessel, TA; Hemontolor, ME; Sastry, BV | 1 |
Ahmed, MS; Hankins, GD; Keyler, DE; Nanovskaya, TN; Nekhayeva, IA; Pentel, PR | 1 |
Auriola, S; Halonen, T; Karttunen, V; Myllynen, P; Myöhänen, K; Vähäkangas, K; Veid, J | 1 |
3 review(s) available for antipyrine and nicotine
Article | Year |
---|---|
[Modification of the action of drugs by inhibition of their metabolism].
Topics: Antipyrine; Barbiturates; Drug Interactions; Enzyme Induction; Enzyme Repression; Ethanol; gamma-Glutamyltransferase; Glucaric Acid; Humans; Nicotine; Pharmaceutical Preparations; Pharmacology; Phenytoin; Rifampin | 1979 |
Role of tobacco smoking in pharmacokinetics.
Topics: Animals; Antipyrine; Cadmium; Carbon Monoxide; Cyanides; Drug Interactions; Humans; Kinetics; Nicotine; Pesticides; Pharmaceutical Preparations; Phenacetin; Polycyclic Compounds; Smoking; Xanthines | 1978 |
Smoking and drug metabolism.
Topics: Antipyrine; Carbon Monoxide; Cyanides; Humans; Nicotiana; Nicotine; Pesticides; Pharmaceutical Preparations; Plants, Toxic; Polycyclic Compounds; Smoke; Smoking; Trace Elements | 1981 |
28 other study(ies) available for antipyrine and nicotine
Article | Year |
---|---|
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
Topics: 1-Octanol; Diffusion; Dimethylpolysiloxanes; Humans; In Vitro Techniques; Membranes, Artificial; Myristates; Permeability; Skin; Skin Absorption; Water | 2006 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of acute electrode placement on regional CBF in the gerbil: a comparison of blood flow measured by hydrogen clearance, [3H]nicotine, and [14C]iodoantipyrine techniques.
Topics: Animals; Antipyrine; Cerebrovascular Circulation; Electrodes; Female; Gerbillinae; Hydrogen; Methods; Nicotine | 1989 |
Sciatic nerve blood flow measured by laser Doppler flowmetry and [14C]iodoantipyrine.
Topics: Animals; Antipyrine; Autoradiography; Blood Pressure; Carbon Radioisotopes; Cobalt Radioisotopes; Male; Microspheres; Nicotine; Rats; Regional Blood Flow; Rheology; Sciatic Nerve; Tritium; Ultrasonography | 1985 |
Genetic control of dicumarol levels in man.
Topics: Adult; Antipyrine; Caffeine; Centrifugation; Coffee; Dicumarol; Female; Genetics, Medical; Humans; Male; Methylcholanthrene; Middle Aged; Nicotine; Phenylbutazone; Pregnancy; Prothrombin Time; Smoking; Spectrophotometry; Twins | 1968 |
Brain uptake of metabolites and drugs following carotid arterial injections.
Topics: Acetates; Amino Acids; Animals; Antipyrine; Ascorbic Acid; Aspirin; Barbiturates; Blood-Brain Barrier; Brain; Caffeine; Chloroquine; Cyanides; Ethanol; Imipramine; Lactates; Mescaline; Morphine; Neurotransmitter Agents; Nicotine; Penicillin G; Pharmaceutical Preparations; Phenytoin; Procaine; Pyruvates; Rats | 1971 |
The in vivo pH of the extravascular space of the lung.
Topics: Amines; Aniline Compounds; Animals; Antipyrine; Atropine; Carbon Dioxide; Dogs; Dye Dilution Technique; Guanidines; Histamine; Hydrogen-Ion Concentration; Indicator Dilution Techniques; Ketones; Lung; Mathematics; Mescaline; Morphine; Nicotine; Oxyphenbutazone; Partial Pressure; Quinine; Radioisotope Dilution Technique; Tritium | 1969 |
Potentiation of a non-narcotic analgesic, dipyrone, by cholinomimetic drugs.
Topics: Animals; Antipyrine; Atropine; Carbachol; Dextroamphetamine; Drug Antagonism; Drug Synergism; Female; Male; Methylamines; Mice; Neostigmine; Nicotine; Physostigmine; Pilocarpine; Sulfonic Acids; Sympathomimetics; Tremorine | 1972 |
Nicotine raises the influx of permeable solutes across the rat blood-brain barrier with little or no capillary recruitment.
Topics: 3-O-Methylglucose; Animals; Antipyrine; Autoradiography; Blood Flow Velocity; Blood-Brain Barrier; Capillaries; Capillary Permeability; Cerebrovascular Circulation; Erythrocyte Count; Kinetics; Male; Methylglucosides; Nicotine; Rats; Rats, Sprague-Dawley; Serum Albumin, Radio-Iodinated | 1995 |
Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon.
Topics: Adult; Antipyrine; Cotinine; Female; Humans; In Vitro Techniques; Maternal-Fetal Exchange; Nicotine; Perfusion; Placenta; Pregnancy | 1998 |
Effects of nicotine-specific antibodies, Nic311 and Nic-IgG, on the transfer of nicotine across the human placenta.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Antipyrine; Drug Evaluation, Preclinical; Female; Humans; Immunoglobulin G; Maternal-Fetal Exchange; Mice; Nicotine; Perfusion; Placenta; Pregnancy; Protein Binding; Rabbits | 2005 |
Acute effects of ethanol on the transfer of nicotine and two dietary carcinogens in human placental perfusion.
Topics: Adenocarcinoma; Antipyrine; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Carbon Radioisotopes; Carcinogens; Cell Line, Tumor; Diffusion; Dimethylnitrosamine; Ethanol; Female; Food Contamination; Humans; Imidazoles; In Vitro Techniques; Indicators and Reagents; Kinetics; Neoplasm Proteins; Nicotine; Perfusion; Placenta; Pregnancy | 2011 |